Conv. Plasma
Nigella Sativa
Peg.. Lambda

All sleep studies
Meta analysis
Home COVID-19 treatment researchSleepSleep (more..)
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta
Cannabidiol Meta Molnupiravir Meta
Colchicine Meta
Conv. Plasma Meta
Curcumin Meta Nigella Sativa Meta
Ensovibep Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Peg.. Lambda Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Ivermectin Meta
Lactoferrin Meta

All Studies   Meta Analysis   Recent:  
0 0.5 1 1.5 2+ Symp. case 32% Improvement Relative Risk Sleep for COVID-19  Cloosterman et al.  Prophylaxis Is better sleep beneficial for COVID-19? Retrospective 2,586 patients in Netherlands Fewer symptomatic cases with higher quality sleep (not stat. sig., p=0.09) Cloosterman et al., J. Science and Med.., Oct 2020 Favors good sleep Favors control

Running behavior and symptoms of respiratory tract infection during the COVID-19 pandemic

Cloosterman et al., Journal of Science and Medicine in Sport, doi:10.1016/j.jsams.2020.10.009
Oct 2020  
  Source   PDF   All Studies   Meta AnalysisMeta
Analysis of 2,586 participants of a running injury prevention RCT in the Netherlands, showing higher risk of COVID-19 symptoms with sleep disturbance.
This study includes exercise and sleep.
risk of symptomatic case, 31.6% lower, RR 0.68, p = 0.09, higher quality sleep 31 of 201 (15.4%), lower quality sleep 222 of 2,385 (9.3%), inverted to make RR<1 favor higher quality sleep, odds ratio converted to relative risk.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Cloosterman et al., 21 Oct 2020, retrospective, Netherlands, peer-reviewed, 4 authors.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperSleepAll
Running behavior and symptoms of respiratory tract infection during the COVID-19 pandemic
Kyra L A Cloosterman, Marienke Van Middelkoop, Patrick Krastman, Robert-Jan De Vos
Journal of Science and Medicine in Sport, doi:10.1016/j.jsams.2020.10.009
Objectives: To explore changes in running behavior due to the Coronavirus Disease 2019 (COVID-19) pandemic, assess presence of symptoms suggestive for COVID-19 and identify whether there is an association between running behavior and COVID-19. Design: Prospective cohort study. Methods: For this study we used a cohort of runners participating in an ongoing randomized controlled trial on running injury prevention among recreational runners. At baseline, demographic and training variables were collected. Seven weeks after starting the lockdown, information on running behavior (interval training, training with partner and physical distancing during training) and running habits (training frequency, duration, distance and speed) were obtained. Furthermore, healthcare utilization and symptoms suggestive for COVID-19 were assessed. To determine the association between running and symptoms suggestive for COVID-19, univariate and multivariate logistic regression analyses were performed. Results: Of the 2586 included participants, 2427 (93.9%) participants continued running during lockdown with no significant changes in mean weekly training variables. A total of 253 participants (9.8%) experienced symptoms suggestive for COVID-19 and 10 participants tested positive for COVID-19. Two participants were admitted to hospital due to COVID-19 with both one day of admission. Running behavior and running habits were not associated with the onset of symptoms suggestive for COVID-19. Conclusions: The large majority of runners in the Netherlands did not change their running habits during lockdown. No association between running behavior or running habits and onset of symptoms suggestive for COVID-19 was identified. This implicates that running outdoor during lockdown does not negatively affect health of runners.
Research and Development (ZonMW), grant number 50-53600-98-104. Appendix A. Supplementary data Supplementary material related to this article can be found, in the online version, at doi: 009.
Ali, COVID-19: are we ready for the second wave?, Disaster Med Public Health Prep
Blocken, Malizia, Van Druenen, Towards aerodynamically equivalent COVID-19 1.5 m social distancing for walking and running
Chen, Mao, Nassis, Coronavirus disease (COVID-19): the need to maintain regular physical activity while taking precautions, J Sport Health Sci
Chen, Zhou, Dong, Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study, Lancet
Fokkema, De Vos, Van Ochten, Preventing running-related injuries using evidence-based online advice: the design of a randomised-controlled trial, BMJ Open Sport Exerc Med
Guan, Ni, Hu, Clinical characteristics of coronavirus disease 2019 in China, N Engl J Med
Huang, Wang, Li, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet
Hull, Loosemore, Schwellnus, Respiratory health in athletes: facing the COVID-19 challenge, Lancet Respir Med
Khammassi, Ouerghi, Said, Continuous moderate-intensity but not high-intensity interval training improves immune function biomarkers in healthy young men, J Strength Cond Res
Simpson, Campbell, Gleeson, Can exercise affect immune function to increase susceptibility to infection?, Exerc Immunol Rev
Sjodin, Wilder-Smith, Osman, Only strict quarantine measures can curb the coronavirus disease (COVID-19) outbreak in Italy, Euro Surveill
Veiligheid, Hardloopblessures Blessurecijfers 2014
Walsh, Recommendations to maintain immune health in athletes, Eur J Sport Sci
Wang, Fang, Zhu, Clinical characteristics of non-critically ill patients with novel coronavirus infection (COVID -19) in a Fangcang Hospital, Clin Microbiol Infect
Wang, Hu, Hu, Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China, JAMA
Zhang, Wang, Rauch, Unprecedented disruption of lives and work: health, distress and life satisfaction of working adults in China one month into the COVID-19 outbreak, Psychiatry Res
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop